Abstract
Coagulation studies were performed on haemophilic patients during a controlled trial of oral contraceptive therapy. Treatment with a combined oestrogen-progestogen preparation was associated with a significant rise in the factor VII-X complex. This change was not observed during treatment with progestogen alone. The highest levels of factor IX and fibrinogen and the lowest levels of factor X were observed during the first period of the trial but these effects were independent of the type of treatment. The results suggest that the effects of oral contraceptives on blood coagulation in haemophilic males are similar to those observed in normal females and that the changes are due to the oestrogenic component.
Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bailar J. C., 3rd Thromboembolism and oestrogen therapy. Lancet. 1967 Sep 9;2(7515):560–560. doi: 10.1016/s0140-6736(67)90529-6. [DOI] [PubMed] [Google Scholar]
- DENSON K. W. The specific assay of Prower-Stuart factor and factor VII. Acta Haematol. 1961 Feb;25:105–120. doi: 10.1159/000206523. [DOI] [PubMed] [Google Scholar]
- DONAYRE J., PINCUS G. EFFECTS OF ENOVID ON BLOOD CLOTTING FACTORS. Metabolism. 1965 Mar;14:SUPPL–SUPPL:421. doi: 10.1016/0026-0495(65)90028-4. [DOI] [PubMed] [Google Scholar]
- Daniel D. G., Bloom A. L., Giddings J. C., Campbell H., Turnbull A. C. Increased factor IX levels in puerperium during administration of diethylstilboestrol. Br Med J. 1968 Mar 30;1(5595):801–803. doi: 10.1136/bmj.1.5595.801. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MILLER S. P., LEE S. L., RITZ N. PROGESTIN-ESTROGEN (SC 11,800) THERAPY AND THE HEMOSTATIC MECHANISM--A CONTROLLED STUDY. Metabolism. 1965 Mar;14:SUPPL–SUPPL:410. doi: 10.1016/0026-0495(65)90026-0. [DOI] [PubMed] [Google Scholar]
- OLIVER M. F., BOYD G. S. Influence of reduction of serum lipids on prognosis of coronary heart-disease. A five-year study using oestrogen. Lancet. 1961 Sep 2;2(7201):499–505. doi: 10.1016/s0140-6736(61)92951-8. [DOI] [PubMed] [Google Scholar]
- Ozsoylu S., Gorbacioglu B. Oral contraceptives for haemophilia. Lancet. 1967 May 6;1(7497):1001–1001. doi: 10.1016/s0140-6736(67)92382-3. [DOI] [PubMed] [Google Scholar]
- PHILLIPS L. L., TURKSOY R. N., SOUTHAM A. L. Influence of ovarian function on the fibrinolytic enzyme system. II. Influence of exogenous steroids. Am J Obstet Gynecol. 1961 Dec;82:1216–1220. doi: 10.1016/s0002-9378(16)36243-3. [DOI] [PubMed] [Google Scholar]
- Poller L., Tabiowo A., Thomson J. M. Effects of low-dose oral contraceptives on blood coagulation. Br Med J. 1968 Jul 27;3(5612):218–221. doi: 10.1136/bmj.3.5612.218. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Poller L., Thomson J. M., Tabiowo A., Priest C. M. Progesterone oral contraception and blood coagulation. Br Med J. 1969 Mar 1;1(5643):554–556. doi: 10.1136/bmj.1.5643.554. [DOI] [PMC free article] [PubMed] [Google Scholar]
- RUTHERFORD R. N., HOUGIE C., BANKS A. L., COBURN W. A. THE EFFECTS OF SEX STEROIDS AND PREGNANCY ON BLOOD COAGULATION FACTORS. A COMPARATIVE STUDY. Obstet Gynecol. 1964 Dec;24:886–892. [PubMed] [Google Scholar]
- TAGNON H. J., SCHULMAN P., WHITMORE W. F., LEONE L. A. Prostatic fibrinolysin; study of a case illustrating role in hemorrhagic diathesis of cancer of the prostate. Am J Med. 1953 Dec;15(6):875–884. doi: 10.1016/0002-9343(53)90178-8. [DOI] [PubMed] [Google Scholar]
- THOMSON J. M., POLLER L. ORAL CONTRACEPTIVE HORMONES AND BLOOD COAGULABILITY. Br Med J. 1965 Jul 31;2(5456):270–273. doi: 10.1136/bmj.2.5456.270. [DOI] [PMC free article] [PubMed] [Google Scholar]
